Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes a protein with similarity to the S. cerevisiae mutagenesis protein Rev1. The Rev1 proteins contain a BRCT domain, which is important in protein-protein interactions. A suggested role for the human Rev1-like protein is as a scaffold that recruits DNA polymerases involved in translesion synthesis (TLS) of damaged DNA. [provided by RefSeq, Mar 2016]
REV1 (REV1 DNA Directed Polymerase) is a Protein Coding gene. Diseases associated with REV1 include Xeroderma Pigmentosum, Variant Type and Trichothiodystrophy 5, Nonphotosensitive. Among its related pathways are Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template and DNA Double-Strand Break Repair. Gene Ontology (GO) annotations related to this gene include magnesium ion binding and DNA-directed DNA polymerase activity. An important paralog of this gene is POLK.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0003677 | DNA binding | IEA | -- |
GO:0003684 | damaged DNA binding | IEA | -- |
GO:0003887 | DNA-directed DNA polymerase activity | IBA | 21873635 |
GO:0005515 | protein binding | IPI | 11485998 |
GO:0016740 | transferase activity | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IBA | -- |
GO:0005654 | nucleoplasm | TAS | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | ||
2 | Fanconi anemia pathway | ||
3 | DNA Double-Strand Break Repair |
.53
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006260 | DNA replication | TAS | 10536157 |
GO:0006281 | DNA repair | IEA | -- |
GO:0006974 | cellular response to DNA damage stimulus | IEA | -- |
GO:0009411 | response to UV | IDA | 11485998 |
GO:0019985 | translesion synthesis | TAS | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Cisplatin | Approved | Pharma | Inhibits DNA synthesis,chemotherapy drug, Potent pro-apoptotic anticancer agent; activates caspase-3, Platinum | 3579 |
ExUns: | 1 | ^ | 2 | ^ | 3a | · | 3b | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10a | · | 10b | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14a | · | 14b | ^ | 15a | · | 15b | ^ | 16a | · | 16b | · | 16c | · | 16d | ^ | 17a | · | 17b | ^ | 18 | ^ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||
SP2: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP3: | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||
SP4: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP5: | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||
SP7: | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
SP8: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP9: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP10: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP11: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP12: | ||||||||||||||||||||||||||||||||||||||||||||||||||||
SP13: |
ExUns: | 19 | ^ | 20 | ^ | 21 | ^ | 22a | · | 22b | · | 22c | ^ | 23a | · | 23b | ^ | 24a | · | 24b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | |||||||||||||||||||
SP2: | |||||||||||||||||||
SP3: | |||||||||||||||||||
SP4: | - | ||||||||||||||||||
SP5: | |||||||||||||||||||
SP6: | - | - | - | - | - | - | |||||||||||||
SP7: | |||||||||||||||||||
SP8: | |||||||||||||||||||
SP9: | |||||||||||||||||||
SP10: | |||||||||||||||||||
SP11: | |||||||||||||||||||
SP12: | |||||||||||||||||||
SP13: |
This gene was present in the common ancestor of animals and fungi.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | REV1 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | REV1 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Rev1 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Rev1 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | REV1 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | REV1 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | REV1 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | REV1 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | REV1 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | rev1 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.32799 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | rev1 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Rev1 30 31 |
|
OneToOne | |
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP005939 30 |
|
||
Worm (Caenorhabditis elegans) |
Secernentea | rev-1 31 |
|
OneToOne | |
Baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | REV1 31 33 |
|
OneToMany | |
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToOne |
SNP ID | Clinical significance and condition | Chr 02 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs145941027 | Benign: not provided | 99,404,456(-) |
T/C NM_016316.4(REV1):c.3033A>G (p.Pro1011=) |
NON_CODING_TRANSCRIPT_VARIANT,SYNONYMOUS | |
rs147808086 | Likely Benign: not provided | 99,439,034(-) |
C/T NM_016316.4(REV1):c.780G>A (p.Glu260=) |
NON_CODING_TRANSCRIPT_VARIANT,SYNONYMOUS_VARIANT,FIVE_PRIME_UTR | |
rs41280589 | Benign: not provided | 99,402,793(-) |
A/T NM_016316.4(REV1):c.3392T>A (p.Leu1131His) |
MISSENSE_VARIANT,NON_CODING_TRANSCRIPT | |
rs28382882 | - |
p.Asn306Asp |
|||
rs28382941 | - |
p.Asp700Asn |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv1977n106 | CNV | deletion | 24896259 |
dgv4032n100 | CNV | gain | 25217958 |
dgv6976n54 | CNV | loss | 21841781 |
dgv84e180 | CNV | gain | 20482838 |
esv2052109 | CNV | deletion | 18987734 |
esv2555492 | CNV | deletion | 19546169 |
esv2658486 | CNV | deletion | 23128226 |
esv2720432 | CNV | deletion | 23290073 |
esv27651 | CNV | gain+loss | 19812545 |
esv33974 | CNV | gain+loss | 17666407 |
esv3559839 | CNV | deletion | 23714750 |
esv3591737 | CNV | loss | 21293372 |
esv4405 | CNV | loss | 18987735 |
nsv1072957 | CNV | deletion | 25765185 |
nsv1072958 | CNV | deletion | 25765185 |
nsv1143947 | CNV | deletion | 24896259 |
nsv1150605 | CNV | deletion | 26484159 |
nsv511799 | CNV | loss | 21212237 |
nsv524466 | CNV | loss | 19592680 |
nsv582524 | CNV | loss | 21841781 |
nsv582525 | CNV | loss | 21841781 |
nsv821279 | CNV | deletion | 20802225 |
nsv829580 | CNV | loss | 20364138 |
nsv829582 | CNV | gain+loss | 20364138 |
Disorder | Aliases | PubMed IDs |
---|---|---|
xeroderma pigmentosum, variant type |
|
|
trichothiodystrophy 5, nonphotosensitive |
|
|
fanconi anemia, complementation group j |
|
|
fanconi anemia, complementation group a |
|
|